Literature DB >> 30365939

Isoquercitrin, a flavonoid glucoside, exerts a positive effect on osteogenesis in vitro and in vivo.

Jing Li1, Xuxia Wang2, Yingzi Wang1, Chengyan Lu3, Dehua Zheng1, Jun Zhang4.   

Abstract

Isoquercitrin (quercetin-3-O-β-d-glucopyranoside) possess various pharmacological effect as a biologically active compound. The aim of the present study was to investigate its potential effects on the proliferation and osteoblastic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) in vitro and bone formation in the mid-palatal suture during rapid maxillary expansion (RME) in vivo. Cell proliferation of rat BMSCs was detected by cell-counting kit- 8 (CCK-8) assay. Alkaline phosphatase (ALP) activity assay and alizarin red staining were used to evaluate osteogenic differentiation of BMSCs. Furthermore, the expression levels of osteogenesis-related genes including runt-related transcription factor 2 (Runx2), bone sialoprotein (BSP) and activating transcription factor 6 (ATF6) were measured by real-time RT-PCR. In vivo, thirty-six male 6-week-old Wistar rats with or without suture expansion receive systemic administration of isoquercitrin or saline solution. Micro-CT, HE and Masson staining were used to compare the morphological changes between the groups. Bone morphogenetic protein 2 (BMP2) expression in the suture was detected using immunohistochemical staining. Our results showed that isoquercitrin significantly promoted cell proliferation, ALP activity and mineral deposition in the range from 0.01 to 1 μM. Moreover, the expression levels of Runx2, BSP and ATF6 were also upregulated. The measurement of micro-CT imaging and histological examinations demonstrated that daily oral administration of isoquercitrin (10 mg/kg) increased bone formation compared to the other groups. Furthermore, the expression level of BMP2 was also augmented in the presence of isoquercitrin. Consequently, those findings showed that isoquercitrin exerts stimulatory effects on osteogenesis in vitro and in vivo, suggesting that isoquercitrin could be a potential candidate for preventing relapse following RME within palatal sutures.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bone marrow-derived mesenchymal stem cells (BMSCs); Bone morphogenetic protein 2 (BMP2); Isoquercitrin; Osteogenesis; Rapid maxillary expansion (RME)

Mesh:

Substances:

Year:  2018        PMID: 30365939     DOI: 10.1016/j.cbi.2018.10.018

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  Isoquercitrin Attenuates Osteogenic Injury in MC3T3 Osteoblastic Cells and the Zebrafish Model via the Keap1-Nrf2-ARE Pathway.

Authors:  Xue Li; Dongyue Zhou; Di Yang; Yunhua Fu; Xingyu Tao; Xuan Hu; Yulin Dai; Hao Yue
Journal:  Molecules       Date:  2022-05-27       Impact factor: 4.927

Review 2.  The Role of Flavonoids in the Osteogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Jinli Zhang; Zhihe Liu; Yang Luo; Xiaojian Li; Guowei Huang; Huan Chen; Aiguo Li; Shengnan Qin
Journal:  Front Pharmacol       Date:  2022-04-06       Impact factor: 5.988

3.  Effect of Puerarin on Osteogenic Differentiation in vitro and on New Bone Formation in vivo.

Authors:  Yanran Yang; Daiyun Chen; Yilin Li; Jinghua Zou; Ruiqi Han; Hongkun Li; Jun Zhang
Journal:  Drug Des Devel Ther       Date:  2022-08-27       Impact factor: 4.319

Review 4.  Treatment of tibial dyschondroplasia with traditional Chinese medicines: "Lesson and future directions".

Authors:  Hui Zhang; Yajing Wang; Khalid Mehmood; Yung-Fu Chang; Zhaoxin Tang; Ying Li
Journal:  Poult Sci       Date:  2020-09-08       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.